Related Experiment Video
Updated: May 17, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
Mumps Hoshino and Torii vaccine strains were distinguished from circulating wild strains
Akihito Sawada1, Yoshiaki Yamaji, Tetsuo Nakayama
1Kitasato Institute for Life Sciences, Laboratory of Viral Infection I, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan.
Abstract:
Aseptic meningitis and acute parotitis have been observed after mumps vaccination. Mumps outbreaks have been reported in Japan because of low vaccine coverage, and molecular differentiation is required to determine whether these cases are vaccine associated. RT-nested PCR was performed in the small hydrophobic gene region, and viruses were differentiated by restriction fragment length polymorphism assay. A total of 584 nucleotides were amplified. The PCR product of the Hoshino strain was cut into two fragments (313 and 271 nucleotides) by MfeI; that of the Torii strain was digested with EcoT22I, resulting in 332- and 252-nucleotide fragments. Both strains were genotype B and had an XbaI site, resulting in two fragments: 299 and 285 nucleotides. Current circulating wild types were cut only by XbaI or MfeI. However, the MfeI site of the wild types was different from that of the Hoshino strain, resulting in 451- and 133-nucleotide fragments. Using three restriction enzymes, two mumps vaccine strains were distinguished from wild types, and this separation was applied to the identification of vaccine-related adverse events.
Insights
Differentiating mumps vaccine strains from wild types is crucial for identifying adverse events. This study developed a molecular method using RT-nested PCR and restriction fragment length polymorphism to distinguish between vaccine and wild mumps virus strains.
Area of Science:
- Virology
- Molecular Biology
- Public Health
Background:
- Mumps vaccination can be associated with aseptic meningitis and acute parotitis.
- Low vaccine coverage in Japan has led to mumps outbreaks, necessitating the identification of vaccine-associated cases.
Purpose of the Study:
- To develop a molecular method for differentiating mumps vaccine strains from wild-type strains.
- To apply this method for identifying vaccine-associated adverse events.
Main Methods:
- RT-nested PCR was employed to amplify the small hydrophobic gene region of the mumps virus.
- Restriction fragment length polymorphism (RFLP) assay using MfeI, EcoT22I, and XbaI enzymes was performed on amplified products.
- Analysis of fragment sizes distinguished between vaccine (Hoshino, Torii) and wild-type strains.
Main Results:
- The Hoshino and Torii vaccine strains (genotype B) showed distinct restriction patterns with MfeI, EcoT22I, and XbaI compared to wild types.
- Wild-type strains were cut by XbaI or MfeI, but the MfeI site differed from that in the Hoshino strain.
- The RFLP assay successfully distinguished the two vaccine strains from circulating wild types.
Conclusions:
- A reliable molecular method using RFLP analysis of RT-nested PCR products can differentiate mumps vaccine strains from wild types.
- This technique is valuable for investigating mumps outbreaks and identifying vaccine-related adverse events.
More Related Videos
Related Concept Videos
Vaccinations
Vaccines
Viral Recombination
Viral Meningitis

